Skip to main content
. 2020 Oct 7;3(10):e2019452. doi: 10.1001/jamanetworkopen.2020.19452

Figure 3. Prevalence of Pathogenic Germline Variants (PGVs), by Age and Number of Cancers.

Figure 3.

Percentage of patients harboring PGVs by age at first cancer diagnosis (A) and number of primary cancer diagnoses at time of germline testing (B). The differences in PGV-positive rate between groups were not statistically significant or were of borderline significance (eg, age 0-19 vs 30-39 years, the largest difference between groups: pairwise P = .03).